bioRxiv · 10.1101/2021.04.08.438924
Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry
Abstract
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been endangering worldwide public health and economy. SARS-CoV-2 infects a variety of tissues where the known receptor ACE2 is low or almost absent, suggesting the existence of alternative pathways for virus entry. Here, we performed a genome-wide barcoded-CRISPRa screen to identify novel host factors that enable SARS-CoV-2 infection. In addition to known host proteins, i.e. ACE2, TMPRSS2 and NRP1, we identified multiple host components, among which LDLRAD3, TMEM30A and CLEC4G were confirmed as functional receptors for SARS-CoV-2. All these membrane proteins bind directly to spikes N-terminal domain (NTD). Their essential and physiological roles have all been confirmed in either neuron or liver cells. In particular, LDLRAD3 and CLEC4G mediate SARS-CoV-2 entry and infection in a fashion independent of ACE2. The identification of the novel receptors and entry mechanisms could advance our understanding of the multiorgan tropism of SARS-CoV-2, and may shed light on the development of the therapeutic countermeasures against COVID-19.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhu, S., Liu, Y., Zhou, Z., Zhang, Z., Xiao, X., Liu, Z., Chen, A., Dong, X., Tian, F., Chen, S., Xu, Y., Wang, C., Li, Q., Niu, X., Pan, Q., Du, S., Xiao, J., Wang, J., Wei, W.. 2021-04-09. Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry. https://doi.org/10.1101/2021.04.08.438924
Cite the original work for its findings. Save a collection to share your selection of sources.